Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
GIA-632 in Dermatitis, Atopic: NCT07220577 Clinical Landscape Report 2026
15 October 2026
NCT07220577 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bimekizumab in Pustulosis of Palms and Soles: NCT07219420 Clinical Landscape Report 2026
15 October 2026
NCT07219420 clinical landscape for Pustulosis of Palms and Soles: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
68Ga-GEH300079 in Ovarian Cancer: NCT07219238 Clinical Landscape Report 2026
15 October 2026
NCT07219238 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Naltrexone Hydrochloride in Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: NCT07221565 Clinical Landscape Report 2026
15 October 2026
NCT07221565 clinical landscape for Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: endpoints, sponsor, phase, geography, readouts, asset context…
9 min read
Methotrexate Sodium in Plaque psoriasis: PACTR202510680658151 Clinical Landscape Report 2026
15 October 2026
PACTR202510680658151 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
FT-836 in Multiple Myeloma: NCT07221032 Clinical Landscape Report 2026
15 October 2026
NCT07221032 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Glyburide in Multiple Sclerosis: NCT07221799 Clinical Landscape Report 2026
15 October 2026
NCT07221799 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Remibrutinib in Multiple Sclerosis, Primary Progressive: NCT07222956 Clinical Landscape Report 2026
15 October 2026
NCT07222956 clinical landscape for Multiple Sclerosis, Primary Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
Sonelokimab in Arthritis, Psoriatic: NCT07223138 Clinical Landscape Report 2026
15 October 2026
NCT07223138 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SKB410 in Non-Muscle Invasive Bladder Neoplasms: NCT07222488 Clinical Landscape Report 2026
15 October 2026
NCT07222488 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Carfilzomib in Relapse multiple myeloma: NCT07222761 Clinical Landscape Report 2026
15 October 2026
NCT07222761 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bleximenib in Acute Myeloid Leukemia: NCT07223814 Clinical Landscape Report 2026
15 October 2026
NCT07223814 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.